Scisparc

Scisparc

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.55-$29.88
Market Cap
$392,912
Shares Short
12,131

Financials

See more
Revenue (12 Mos)
$679,000
Revenue Growth (YoY)
-38.4%
Gross Profit (12 Mos)
$6.4M
Diluted EPS
$248.24

News

See more

Yahoo Finance • 28 days ago

SciSparc: Subsidiary NeuroThera Labs’ CliniQuantum Reports Successful Quantum-Enabled Analysis of Billions of Gene Combinations Using Real-World Clinical Data on an S&P 500 Company’s Quantum Architecture

Yahoo Finance • 2 months ago

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation for Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

Yahoo Finance • 2 months ago

SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

Yahoo Finance • 3 months ago

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company

About

CEO
Mr. Oz Adler CPA
CFO
Mr. Oz Adler CPA
Address
Tower A, Tel Aviv-Yafo, Israel, 6971916
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
3